We found that the expression of REV7 (Figure 1a) was significantly increased in the glioma tissue compared with that in the normal tissue (p < 0.05); the expression of REV3L also increased in the glioma tissue, but no significant differences were observed (Figure 1b, p > 0.05). Here, REV3L is linked to central nervous system cancer.